{"id":231743,"date":"2026-09-04T14:22:57","date_gmt":"2026-09-04T08:52:57","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=231743"},"modified":"2026-09-04T14:23:00","modified_gmt":"2026-09-04T08:53:00","slug":"is-usha-martin-a-good-buy-after-q1-fy27-results","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/is-usha-martin-a-good-buy-after-q1-fy27-results\/","title":{"rendered":"Is Usha Martin a Good Buy After Its Q1 FY27 Results?"},"content":{"rendered":"
<\/div>\n

Usha Martin share price around Rs 519. 1.7% below 52-week high of Rs 528. Q1 FY27 revenue Rs 1,042 crore, up 15.4% YoY. PAT Rs 142 crore, up 40.9%. PE 31x.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

Usha Martin’s Q1 FY27 results were strong, with revenue at Rs 1,042 crore and PAT climbing 41% to Rs 142 crore. The stock trades at a PE of 31x against an industry average near 24x, so some of this good news is already priced in. The Usha Martin share price near Rs 519 reflects that optimism, so investors weighing whether Usha Martin is a good buy today should focus on whether this pace of growth can be sustained rather than just this quarter’s print.<\/p>\n<\/div>\n

The Usha Martin share price has been under the spotlight this results season after the company reported its first-quarter numbers for FY27. Usha Martin is a specialty steel wire rope manufacturer serving mining, infrastructure and industrial sectors, and its Q1 FY27 print, for the quarter ended June 30, 2026, gives investors a fresh data point to test whether the stock still deserves a place in a portfolio at current levels.<\/p>\n

Revenue for the quarter came in at Rs 1,042 crore, up 15.4% year on year, while profit after tax came in at Rs 142 crore, up 40.9% from a year earlier. That combination of numbers is exactly what this article breaks down, along with what it means for the Usha Martin share price from here.<\/p>\n

This piece works through the quarter’s financial highlights, the business factors behind the numbers, where the Usha Martin share price stands against its 52-week range and valuation multiples, and the key risks worth watching before treating this as a buy, hold or a stock to avoid for now.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n